Indivior PLC Director Declaration (6702H)
17 November 2018 - 2:52AM
UK Regulatory
TIDMINDV
RNS Number : 6702H
Indivior PLC
16 November 2018
Indivior PLC - Director Declaration
Indivior PLC confirms that Daniel Tassé, Senior Independent
Director, will be appointed Chief Executive Officer of DBV
Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq: DBVT), a
clinical stage biopharmaceutical company, with effect from November
29, 2018.
There have been no other changes to the information set out in
LR 9.6.13R (2) to LR 9.6.13R (6) in respect of Mr Tassé.
This announcement is made in accordance with Listing Rule
9.6.14.
Kathryn Hudson
Company Secretary
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RDNFKADQPBDDFDD
(END) Dow Jones Newswires
November 16, 2018 10:52 ET (15:52 GMT)
Indivior (LSE:INDV)
Historical Stock Chart
From Apr 2024 to May 2024
Indivior (LSE:INDV)
Historical Stock Chart
From May 2023 to May 2024